BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2190387)

  • 1. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
    Sridhar N; Schroeder TJ; Pesce AJ; First MR
    Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation and therapeutic range of cyclosporine A as monitored by FPIA in kidney transplantation.
    Nattermann U; Steimer W; Gokel JM; Seidel D; Land W
    Transplant Proc; 1990 Jun; 22(3):1284-6. PubMed ID: 2190391
    [No Abstract]   [Full Text] [Related]  

  • 3. Steady-state concentrations of cyclosporine for therapeutic monitoring.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1339-42. PubMed ID: 2190397
    [No Abstract]   [Full Text] [Related]  

  • 4. Summary on therapeutic drug monitoring for renal transplantation.
    Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1348-51. PubMed ID: 2190398
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a sheep polyclonal antibody: II. Evaluation of the whole blood methodology and comparison with an 3H tracer-mediated radioimmunoassay with a sheep polyclonal antibody.
    Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1181-5. PubMed ID: 2190378
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility.
    Shaw LM; Audet PR; Grossman RA; Fields L; Lensmeyer GL; Dafoe DC
    Transplant Proc; 1990 Jun; 22(3):1267-73. PubMed ID: 2349688
    [No Abstract]   [Full Text] [Related]  

  • 7. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
    Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the utility of 3H-based specific monoclonal antibody assay on whole blood samples with the fluorescence polarization nonspecific immunoassay on serum samples for diagnosis of adverse events in renal transplant patients.
    Kahan BD; Napoli K; Welsh M; Grevel J; Rutzky LP
    Transplant Proc; 1990 Jun; 22(3):1274-9. PubMed ID: 2190389
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a rabbit polyclonal antibody: I. Evaluation of the serum methodology and comparison with a sheep polyclonal antibody in an 3H-tracer mediated radioimmunoassay.
    Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1175-80. PubMed ID: 2190377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
    Stiller C; Keown P
    Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
    [No Abstract]   [Full Text] [Related]  

  • 12. Japanese conference on cyclosporine blood level monitoring.
    Takagi H; Uchida K
    Transplant Proc; 1990 Jun; 22(3):1224-5. PubMed ID: 2190384
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of cyclosporine monitoring by nonselective fluorescence polarization immunoassay.
    Pesce AJ; Schroeder TJ; First MR
    Transplant Proc; 1990 Jun; 22(3):1171-4. PubMed ID: 2190376
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective study of cyclosporine monitoring in renal transplantation.
    Lindholm A
    Transplant Proc; 1990 Jun; 22(3):1260-3. PubMed ID: 2190388
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine--high-dose steroid interaction in renal transplant recipients: assessment by HPLC.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ; Hakala TR; Rosenthal JT; Carpenter BJ; Taylor RJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1728-9. PubMed ID: 3274417
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality assessment of cyclosporine measurements: comparison of current methods.
    Holt DW; Marsden JT; Johnston A
    Transplant Proc; 1990 Jun; 22(3):1234-9. PubMed ID: 2190385
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver transplantation in Birmingham--use of cyclosporine--clinical correlations with drug measurements.
    Gunson BK; Jones SR; Buckels JA; Jain AB; McMaster P
    Transplant Proc; 1990 Jun; 22(3):1312-8. PubMed ID: 2349692
    [No Abstract]   [Full Text] [Related]  

  • 18. Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine.
    Transplant Proc; 1990 Jun; 22(3):1357-61. PubMed ID: 2190399
    [No Abstract]   [Full Text] [Related]  

  • 19. French multicentre study: comparison of two specific and four nonspecific methods for Sandimmune (cyclosporine) blood and plasma (separated at 37 degrees C or at 22 degrees C) monitoring.
    Vernillet L; Humbert H; Aupetit B; Berard M; Bertault-Peres P; Billaud E; Bizollon CA; Breteau M; Brisson AM; Codet JP
    Transplant Proc; 1990 Jun; 22(3):1218-23. PubMed ID: 2190383
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclophilin binding: a receptor-mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation.
    Lorber MI; Paul K; Harding MW; Handschumacher RE; Marks WH
    Transplant Proc; 1990 Jun; 22(3):1240-4. PubMed ID: 2190386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.